IP Verse

N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)-Phenyl]-Acetamide Free Base Hemihydrate, Methods Of Manufacture And Uses Thereof

Patent No. EP3544976 (titled "N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)-Phenyl]-Acetamide Free Base Hemihydrate, Methods Of Manufacture And Uses Thereof") was filed by Aicuris on Nov 28, 2017. The application was issued on Feb 17, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
INNOVATIVE MOLECULESNov 17, 2021GILLE HRABAL PARTNERSCHAFTSGESELLSCHAFT MBB PATENTANWALTE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3544976

AICURIS
Application Number
EP17811883A
Filing Date
Nov 28, 2017
Status
Opposition Rejected
Feb 23, 2024
Publication Date
Feb 17, 2021
External Links
Slate, EP3544976B1, Google Patents